ClinicalTrials.gov
ClinicalTrials.gov Menu

Nimotuzumab in Combination With Cisplatin and Docetaxel for Patients With Advanced Non-small Cell Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00985998
Recruitment Status : Withdrawn (no paticipants enrolled)
First Posted : September 29, 2009
Last Update Posted : August 19, 2015
Sponsor:
Information provided by (Responsible Party):
Biotech Pharmaceutical Co., Ltd.

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Actual Primary Completion Date : August 2015
  Actual Study Completion Date : August 2015